Sort
166,118 grants matching “stem cells”
A Biomechanocompatible Small Molecule Releasing Scaffold for Bladder Augmentation
$708,138Arun Sharma · Lurie Children'S Hospital Of Chicago · R01 · FY2025 · DK
Targeting autophagy to reduce inflammasome-mediated inflammation and immune dysfunction in HIV and methamphetamine use
$708,134Anjie Zhen · University Of California Los Angeles · R01 · FY2025 · DA
CCR-Frederick Flow Cytometry Core
$708,100Kathleen Noer · Division Of Basic Sciences - Nci · ZIC · FY2015 · CA
Inter- and Intra-cellular effects of cannabinoids, HIV and ART in the CNS
$708,072Kelly L Jordan-Sciutto · University Of Pennsylvania · R01 · FY2022 · DA
Metabolic Regulation of Insulin Secretion
$708,066Barbara E. Corkey · Boston Medical Center · R01 · FY2010 · DK
Dexamethasone as an Effective Therapy for Ocular Injuries by Vesicating Agents.
$708,058Rajesh Agarwal · University Of Colorado Denver · U01 · FY2023 · EY
Targeting Protein Arginine Methyltransferases to Eradicate Acute Myeloid Leukemia
$708,057Ling Li · Beckman Research Institute/City Of Hope · R01 · FY2025 · CA
Contributions of human C4A overexpression to schizophrenia pathogenesis.
$708,000Beth Ann Stevens · Boston Children'S Hospital · P50 · FY2023 · MH
Exploring HIV-associated Neurocognitive Disorder (HAND) and HIV Latency at the Single Cell Level in Cerebral Organoids
$708,000Melanie Maria Ott · J. David Gladstone Institutes · R01 · FY2022 · DA
Contributions of human C4A overexpression to schizophrenia pathogenesis.
$708,000Beth Ann Stevens · Boston Children'S Hospital · P50 · FY2025 · MH
Exploring HIV-associated Neurocognitive Disorder (HAND) and HIV Latency at the Single Cell Level in Cerebral Organoids
$708,000Melanie Maria Ott · J. David Gladstone Institutes · R01 · FY2023 · DA
Exploring HIV-associated Neurocognitive Disorder (HAND) and HIV Latency at the Single Cell Level in Cerebral Organoids
$708,000Warner C Greene · J. David Gladstone Institutes · R01 · FY2021 · DA
Contributions of human C4A overexpression to schizophrenia pathogenesis.
$708,000Beth Ann Stevens · Boston Children'S Hospital · P50 · FY2024 · MH
Exploring HIV-associated Neurocognitive Disorder (HAND) and HIV Latency at the Single Cell Level in Cerebral Organoids
$708,000Warner C Greene · J. David Gladstone Institutes · R01 · FY2020 · DA
Exploring HIV-associated Neurocognitive Disorder (HAND) and HIV Latency at the Single Cell Level in Cerebral Organoids
$708,000Warner C Greene · J. David Gladstone Institutes · R01 · FY2019 · DA
Contributions of human C4A overexpression to schizophrenia pathogenesis.
$708,000Beth Ann Stevens · Boston Children'S Hospital · P50 · FY2022 · MH
Targeting autophagy to reduce inflammasome-mediated inflammation and immune dysfunction in HIV and methamphetamine use
$707,947Anjie Zhen · University Of California Los Angeles · R01 · FY2024 · DA
Low-Cost Instrument-free Point-of-care Platform for Multiplexed Chlamydia Diagnostics
$707,926Debkishore Mitra · Lucira Health, Inc · R44 · FY2016 · AI
Adenylyl Cyclase Type VI for CHF
$707,895H. Kirk Hammond · Veterans Medical Research Fdn/San Diego · P01 · FY2006 · HL
Stress and Human Stem/Progenitor Cells: Biobehavioral Mechanisms
$707,876Pathik D Wadhwa · University Of California-Irvine · R01 · FY2022 · HD
The role of inflammation in driving leukemogenesis in germline predisposition syndromes
$707,850Lucy Ann Godley · University Of Chicago · U01 · FY2022 · CA
Chromosome Inheritance
$707,834Bruce W Stillman · Cold Spring Harbor Laboratory · P01 · FY2008 · CA
A Phase II Controlled Trial of Allogeneic Mesenchymal Stem Cells for the Treatment of Refractory Lupus
$707,818Gary S. Gilkeson · Medical University Of South Carolina · U01 · FY2020 · AI
A Phase II Controlled Trial of Allogeneic Mesenchymal Stem Cells for the Treatment of Refractory Lupus
$707,818Gary S. Gilkeson · Medical University Of South Carolina · U01 · FY2021 · AI
A Phase II Controlled Trial of Allogeneic Mesenchymal Stem Cells for the Treatment of Refractory Lupus
$707,818Gary S. Gilkeson · Medical University Of South Carolina · U01 · FY2019 · AI